![]() |
Volumn 8, Issue 6, 2007, Pages 460-461
|
Angiogenesis and lung cancer: implications for prognosis and treatment
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTINEOPLASTIC AGENT;
BEVACIZUMAB;
BIOLOGICAL MARKER;
ANGIOGENESIS;
CANCER MORTALITY;
CANCER RESEARCH;
CANCER STAGING;
CANCER SURVIVAL;
CORRELATION ANALYSIS;
FOOD AND DRUG ADMINISTRATION;
GENE EXPRESSION PROFILING;
HISTOPATHOLOGY;
HUMAN;
IMMUNOHISTOCHEMISTRY;
INDIVIDUALIZATION;
LETTER;
LUNG CANCER;
LUNG RESECTION;
MATERIALS HANDLING;
METASTASIS POTENTIAL;
PATIENT CARE;
PATIENT MONITORING;
PATIENT SELECTION;
PRIORITY JOURNAL;
PROGNOSIS;
SCORING SYSTEM;
TUMOR VASCULARIZATION;
UNITED STATES;
UNSPECIFIED SIDE EFFECT;
HUMANS;
LUNG NEOPLASMS;
NEOVASCULARIZATION, PATHOLOGIC;
PROGNOSIS;
|
EID: 34249325824
PISSN: 14702045
EISSN: None
Source Type: Journal
DOI: 10.1016/S1470-2045(07)70153-5 Document Type: Letter |
Times cited : (9)
|
References (7)
|